(Part 2) Joseph Ramahi, PhD, a tissue culture specialist, discovered the difficulty of identifying Hop Latent Viroid (HpLVd) in cannabis and hemp plants, as it displayed both symptomatic and asymptomatic characteristics. HpLVd can lead to “dudding”, a stunted growth with less flower production and reduced trichomes. We discuss this discovery and the actions growers can take with our guest Joseph Ramahi, PhD, CSO of Cultivaris Hemp and on the board of Apical Biotek. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Periodic effects Cannabis Business & Science

Pe193 The Fears of Cannabis Monocropping

(Part 1) Joseph Ramahi, PhD, a plant molecular biologist, was stunned as he discovered the widespread infection rates of Hop Latent Viroid (HpLVd) in cannabis crops. While this new viroid to cannabis was only publicly announced in 2019, it was initially discovered in the hops industry. We discuss the what, why, where and when of HpLVd with our guest Joseph Ramahi, PhD, CSO of Cultivaris Hemp and on the board of Apical Biotek. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Pe192 Puzzling Pathogen is Killing Cannabis Crops

“Indica” & “Sativa” are often used to describe cannabis experiences, but the accuracy of these terms for predicting effects is hotly debated. Do “indica” and “sativa” strains actually have common terpenes that can consistently influence how you’ll feel on consumption? In this new podcast series, we’ll explore a study into the real chemistry behind the effects of sativa & indica cannabis by past guest Arno Hazekamp, PhD. Budtenders can join the [Pbs] FB Group Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message Paper Discussed [1] “Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification” by Arno Hazekamp, Katerina Tejkalová, and Stelios Papadimitriou

Pbs080_From Cultivar to Chemovar_Part 1

Arno Hazekamp, PhD (Part 2) discusses data correlations he discovered that might actually show Sativa & Indica do have specific types of terpenes, and therefore specific effects. Arno explains how terpenes and terpenoids are not the same thing, and how alcoholic terpenes (terpenoids) might be associated with Indica strains by influencing, or being a byproduct of, the growth properties of the cannabis plant. Arno’s Paper, Cannabis: From Cultivar to Chemovar II - A Metabolomics Approach to Cannabis Classification Learn about the work of Arno’s consultancy at Legal Cannabis Coalition Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Pe191 Could Sativa & Indica Actually Equal Effects?

Arno Hazekamp, PhD (Part 1) has been researching medicinal cannabis in Holland since 2001. We discuss transitioning from a cultivar to chemovar classification system for cannabis, and how this is needed to bridge the gap between patients, doctors, growers and products. In the second half of our conversation, Arno points out that indica and sativa might actually have specific terpenes associated with them, and therefore specific effects. Arno’s Paper, Cannabis: From Cultivar to Chemovar II - A Metabolomics Approach to Cannabis Classification Learn about the work of Arno’s consultancy at Legal Cannabis Coalition Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Pe190 The 1st Cannabis Research Scientist in Holland

A series not just for Budtenders. Let’s move beyond cannabinoids & terpenes to the more mysterious compounds of the cannabis leaves. Discover what science currently knows about Cannflavin A, Cannflavin B, and Bi-Benzyl compounds as well as the future potential of these trace cannabis molecules. Budtenders can join the [Pbs] FB Group Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Pbs079_Cannabis Pharmacology series_part 14_Cannabis Flavonoids & Bi-Benzyl Compounds

Sasha Kalcheff-Korn became the Education Coordinator at Realm of Caring (RoC) after teaching mathematics and getting her Masters in International Human Rights. RoC has the largest observational research registry on cannabis in partnership with Johns Hopkins University. We discuss that database, some studies and Sasha’s approach to educating different parts of the mainstream, like medical professionals, patients and the broader community. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Pe189 Largest Cannabis Observational Research Registry

Part 2 - Sam Chapman pictures a future medical mushroom program in Oregon with life-changing experiences available right next door for adults who can benefit from psilocybin. This would include a boom in job creation for facilitators & service centers to administer psilocybin therapy - but likely not as much opportunity on the supply side as in cannabis. Sam discusses the next two years of rulemaking for Measure 109’s program implementation, and how we can learn important lessons from cannabis’s legalization path. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Pe188 Psilocybin Key Roles = Facilitators & Service Centers

Part 1 - Sam Chapman co-authored HB3460 in 2013, which legalized medical marijuana dispensaries in Oregon. More recently, Sam was the campaign manager of Measure 109 that passed and legalized a medical psilocybin program in Oregon. We discuss his advocacy journey from cannabis to psilocybin and what it looked like behind the scenes under such an unpredictable and dynamic landscape. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Pe187 Legalization Tales from the Source

From a 1-on-1 call with Wayne. Terese is a cannabis coach in Canada where many unknowns remain on the future landscape of cannabis markets. We discuss future predictions based on the current work Terese is doing and the changes taking place. If you’re a cannabis coach interacting with medical patients or consumers, this is a good episode to check out. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Pe186 Are you a Cannabis Coach?

Part 2 - Back with Dr. Sulak to discuss the use cases of new and emerging molecules in medicine, and how those might integrate around cannabis. We discuss the science of Kratom, Psilocybin and Ketamine. Covering the science currently known and unknown with these medicines and what the future landscape might look like. Our guest is Dr. Dustin Sulak, Founder of Healer Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Pe185 Kratom, Psilocybin & Ketamine: Science & Use Cases

Part 1 - Dr. Sulak is a leading physician on integrating cannabis and other emerging plant medicines into his practice, while educating medical providers and patients on the clinical use of these medicines. We discuss “molecules” in this episode and their potential use cases. More so we discuss new findings and applications for cannabis molecules that have been sitting in the dark. Our guest is Dr. Dustin Sulak, Founder of Healer Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Pe184 New Applications for Cannabis Molecules

From a 1-on-1 call with Wayne. Dr. Quinn owns a compounding pharmacy along with multiple ventures in the cannabis industry. We discuss a recent “hammer” big pharma dropped on the compounding world, which made a legal Cannabidiol product now illegal to use. And why the current insurance companies will never cover medical cannabis products from a compounding pharmacy. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Pe183 Insider Secrets of Cannabis Compounding Pharmacies

From a 1-on-1 call with Wayne. Joe is a pharmacist that became interested in cannabis. After joining a Multi-State Operator as their Pharmacy Director, he’s concerned about the roll out of rec markets and what the future of pharmacists will be around cannabis for medical use. We discuss Joe’s current path and day to day in the business. What his biggest challenges are and how rec markets may (or may not) destroy the medical side of cannabis for patients. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST)

Pe182 Pharmacists Anxious about Rec Cannabis Rollouts

Brock thought his business was doomed when the IRS came knocking. However after much struggle, he was able to overcome the odds. We discuss how he did that, and why he decided to help support the legalization of medical psilocybin (magic mushrooms) in Oregon. As Oregon hurries to create regulations and licensing for psilocybin use, what will the future look like? Our guest is Brock Binder, Founder of High Quality, and we cover the knowns and unknowns of the laws, regulations, business landscape and personal use of psilocybin. Join Newsletter & get mini podcast style videos from Wayne Schedule Wayne 1-on-1 call (Office Hours, Fri 2-4pm PST) Send us a Message

Pe181 The Landscape of Psilocybin Legalization in Oregon

Periodic effects brings you an insider look at cannabis business operators and the latest studies on cannabis science research. If you’re operating in the cannabis industry, a budtender looking to learn more, or a consumer wondering how cannabis can help you, this is the podcast for you!

hubhopper

Periodic effects Cannabis Business & Science

hubhopper